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Abstract
Bikunin and a -microglobulin are two plasma proteins of about 25 kDa which are made in the liver from a common1
precursor. The concentration of bikunin in human urine has been shown to increase several fold during various conditions of
stress. The mechanism behind this increase is unknown. We have studied pregnant rats and found that the bikunin and
a -microglobulin levels in their urine increased 3-fold towards the end of the pregnancy, whereas those of albumin and1
orosomucoid did not. There were no significant changes in either the bikuninra -microglobulin mRNA level or the1
concentrations of the two proteins in serum. These findings imply that the synthesis and the clearance rates of bikunin and
a -microglobulin are normal during pregnancy but that the tubular reabsorption of these proteins is decreased. q 19971
Elsevier Science B.V.
Keywords: Bikunin; a -microglobulin; Pregnancy; Urine; Reabsorption1
1. Introduction
Bikunin is a plasma protein of 25 kDa which
consists of two similar domains, each with proteinase
w xinhibitory activity 1,2 . The physiological role of
bikunin is unclear but the protein has been shown to
affect the metastasis of cancer cells — possibly by
w xinhibiting plasmin 3,4 . Bikunin has also been re-
w xported to stimulate cell growth 5,6 and to block the
) Corresponding author. Fax: q46 18 174975. E-mail:
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release of intracellular Ca2q induced by lipopoly-
w xsaccharide 7 . The primary translation product of the
mRNA coding for bikunin is a precursor also contain-
w xing a -microglobulin 8 . The precursor is cleaved1
intracellularly and the two proteins are secreted sepa-
rately. a -microglobulin has been shown to affect1
w xinflammatory and immune reactions 9 . In the blood,
most of bikunin and a -microglobulin occurs in com-1
w xplex with other, larger polypeptides 10–12 .
Experiments with radiolabelled bikunin have
shown that the protein has a plasma half-life of about
10 min and that the kidneys account for approxi-
w xmately half of the uptake 13 . Bikunin is the major
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w xproteinase inhibitor of urine 14 and has often been
referred to as the urinary trypsin inhibitor. A protein
that might be identical to bikunin has been found to
w xbe an inhibitor of kidney stone formation 15 . It has
been known for almost a century that the bikunin
concentration in human urine initially measured as
.antitryptic activity increases several fold during
pregnancy and under various disease conditions such
 w x.as infection and fever reviewed by Faarvang 16 ;
similar observations have been made for a -micro-1
w xglobulin 9 . It has been suggested that these in-
creases might be due to an increased synthesis of the
 w x.two proteins acute phase reaction 17 or to prote-
olytic release from high molecular weight complexes
w x18,19 . Using the rat as a model, we show in this
study that the increase of the urinary levels of bikunin
and a -microglobulin during pregnancy is due to1
decreased tubular reabsorption.
2. Materials and methods
2.1. Plasma and urine collection
 .Female virgin Sprague-Dawley rats 200–280 g
were kept in cages with free access to water and
standardized diet R36; Lactamin, Stockholm, Swe-
.den . They were mated overnight and conception was
assessed by a vaginal smear on the following morn-
ing; this day was taken as day 0 of the pregnancy.
For urine collection, the animals were transferred to
metabolical cages where they were kept for 16–20 h,
unless specified otherwise. Before the rats were re-
turned to standard cages, a blood sample was taken
from the tip of the tail.
2.2. Protein analysis of plasma and urine samples
The bikunin concentration was measured with a
w xradioimmunoassay as previously described 2 ;
bikunin linked to other polypeptides was removed by
w xperchloric acid precipitation 2 . The concentrations
w xof a -microglobulin and orosomucoid 20 were also1
determined with radioimmunoassays. The creatinine
and protein contents of urine were measured with
colorimetric assays Sigma Diagnostics, USA and
.Protein Assay, BioRad, USA, respectively .
2.3. RNA preparation and northern blot analysis
mRNA was isolated directly from homogenates of
liver and kidney tissues obtained from control and
 .pregnant rats after 16 days of pregnancy by the use
of magnetic particles PolyATract System 1000;
. Promega; Madison, USA . The obtained mRNA 1
.mg was denatured by formaldehyde, separated by
electrophoresis and blotted onto a membrane Hy-
.bond-Nq ; Amersham; Buckinghamshire, UK . A
full-length clone of rat cDNA for a -microglobulin-1
bikunin was used as a probe; labelling was made with
w 32 x a- P dCTP Megaprime DNA labelling kit; Amer-
.sham; Buckinghamshire, UK . Hybridization was
performed for 2 h at 658C in Rapid-hyb buffer
 .Amersham; Buckinghamshire, UK . The membrane
was washed for 20 min in 2=SSC 30 mM Na3
.citrate, 300 mM NaCl, pH 7.0 , 0.1% SDS at room
temperature and then 2=15 min in 0.1=SSC, 0.1%
SDS at 658C. Finally, the membrane was exposed to
Fuji RX film overnight. The probe was removed from
the membrane by a 10 minute immersion in boiling
 .SDS 0.5% . Subsequently, the relative amounts of
mRNA in each lane were determined by hybridiza-
tion with a 700 bp fragment of cDNA coding for
human glyceraldehyde-3-phosphate-dehydrogenase
 . w xGAPDH 21 .
3. Results
3.1. Protein le˝els in urine during pregnancy
As an introduction to this study, we measured the
urinary level of bikunin of normal rats during a few
days after their transfer to metabolic cages. As previ-
w xously shown for humans 16 , we found that the
urinary level of bikunin varied greatly between dif-
 .ferent rats Fig. 1 . The daily variation was also
striking; comparison of the patterns from several rats
showed that the level during the night was generally
higher than during the day. Similarly, the bikunin
concentration of human urine has been shown to
w xincrease with increasing physical activity 22 . We
also noted that the bikunin level was elevated during
the first day in the metabolic cage. All subsequent
analyses were therefore done with animals which had
previously been in this cage for at least one day.
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Fig. 1. Bikunin level in urine of normal rats. Two rats were
transferred for the first time to metabolic cages and urine was
collected. At the times indicated, urine was withdrawn and the
concentrations of bikunin and creatinine determined. The effect
of variations in the glomerular filtration rate was eliminated by
dividing the bikunin value with that of creatinine. The stippled
regions indicate time periods without light. The obtained results
illustrate the facts that the bikunin level varies during the day and
night and that the average level may be very different for
different animals.
 .Fig. 2 top and middle panels, open circles shows
that the bikunin and a -microglobulin levels in urine1
collected from normal animals during 16–20 h inter-
vals were relatively constant during a period of 20
days. During pregnancy, however, the levels in-
 .creased 2- to 3-fold closed circles . The individual
variation was large: of 12 pregnant rats studied, 3
showed less than 50% of increase and one a 5-fold
increase of the bikunin concentration. The individual
levels prior to pregnancy varied by "70% and the
results are therefore shown relative to the initial value
for each rat.
The urine was also assayed for orosomucoid, an
w xacute phase protein 23 of 45 kDa. The level of this
protein did not increase during pregnancy Fig. 2,
.bottom left-hand panel showing that the observed
effects were not due to inflammation. We also found
that the protein concentration of the urine varied
-"30% during the duration of the experiment data
.not shown . Furthermore, analysis by gel elec-
trophoresis showed that albumin was the most abun-
dant urinary protein and that the concentration of this
protein did not change significantly. The serum levels
of bikunin, a -microglobulin and orosomucoid were1
 .also determined Fig. 2, right-hand panels which
Fig. 2. Effect of pregnancy on the levels of bikunin, a -micro-1
globulin and orosomucoid in rat urine and plasma. Rats were
mated and after the number of days indicated, they were kept for
16–20 h in metabolic cages for urine collection. At the end of
this period a blood sample was taken. The concentrations of
different proteins were then determined with radioimmunoassays.
For the determination of the level of bikunin in free form,
complexed bikunin was first removed by precipitation with per-
chloric acid. The protein concentrations in the urine were divided
by the corresponding creatinine concentrations as described in
Fig. 1. Shown are the protein levels relative to the initial value
for each rat which was set at one. Open and closed circles
represent values obtained for control and pregnant rats, respec-
tively; SEMs are indicated by bars. 4–9 animals were used for
each time series. A nonparametric, paired t-test was used to
evaluate the statistical significance of the differences between the
)values of day 1 and those of days 8, 15 and 20 P -0.05,
)) .P -0.01 .
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showed that these did not significantly increase dur-
ing pregnancy.
3.2. Le˝el of bikuninra -microglobulin mRNA1
during pregnancy
To see if the increase of the bikunin and a -micro-1
globulin levels in urine upon pregnancy could be
caused by an increase in the production of the two
proteins, we determined the relative amounts of their
mRNA in liver tissue. For this analysis we used rats
whose urinary bikunin level were found to increase at
least 2-fold towards the end of the pregnancy. Using
a -microglobulinrbikunin cDNA as the probe, we1
w xdetected one mRNA species of the expected size 24 :
 .1.3 kb Fig. 3 . The amount of this mRNA relative to
 .that of GAPDH in arbitrary units in normal and
pregnant rats were 7.1"0.4 mean"SEM; 5 ani-
.  .mals and 6.8"0.5 5 animals , respectively. The
difference between these values is not statistically
significant as judged by an unpaired t-test. To see if
the increased urinary levels of bikuninra -micro-1
globulin was due to synthesis of the two proteins in
the kidneys, we also measured the mRNA level in
this tissue: there were less than 0.1 U.
Fig. 3. Determination of mRNA levels for bikuninra1-micro-
globulin in rat liver and kidney. mRNA was isolated from the
homogenates of liver and kidney, fractionated by gel elec-
trophoresis and transferred to a membrane. mRNA for
bikuninra1-microglobulin was detected with a specific probe
32  .labelled with P upper panel ; the positions of reference mRNA
molecules run in parallel are shown to the right with their sizes in
kilobases. The amount of GAPDH mRNA — an indicator for the
amount of mRNA loaded on each lane — was determined by the
 .same technique lower panel .
4. Discussion
In this study we have found that the concentrations
of bikunin and a -microglobulin in the urine of rats1
increase during pregnancy. We also show that preg-
nancy does not affect the level of the bikuninra -mi-1
croglobulin mRNA indicating that the production of
the two proteins is constant. Furthermore, we found
that the serum concentrations of the two proteins
were unaffected implying that their clearance rates
are not affected by pregnancy. We have previously
shown that approximately half of the uptake of
bikunin occurs in the kidneys and that bikunin is
w xfiltered through the glomeruli 13 . Proteins that pass
through the glomeruli are efficiently reabsorbed in
the proximal tubuli with the result that only a small
fraction of the amount in the filtrate appears in the
w xurine 25 . This fact together with our experimental
observations suggests that the cause for the increase
of urinary bikunin and a -microglobulin levels dur-1
ing pregnancy is that the efficiency of their reabsorp-
tion decreases. An alternative explanation would be
that there is an increased rate of translation of the
bikuninra -microglobulin mRNA during pregnancy1
which would be balanced by an increased clearance
rate. However, we have previously shown that the
rate at which bikunin is filtered through the kidneys
is remarkably high considering the fact that the hy-
drodynamic size of bikunin is close to that of bikunin
w x26 ; if the kidneys only would account for the clear-
ance, the half-life of bikunin would be about 20 min
w x13 . A several fold increase of the clearance rate of
bikunin therefore seems very unlikely. Furthermore,
we found that the plasma half-life of i.v. injected
bikunin labelled with 125I was the same in pregnant
 .and control animals unpublished observation . A
second alternative explanation for the increase of
a -microglobulin and bikunin in urine would be that1
pregnancy induces synthesis of the two proteins in
the kidneys. However, this possibility can be ruled
out since we could not detect a significant amount of
the corresponding mRNA in this tissue.
During the intracellular transport of newly synthe-
sized bikunin approximately two thirds becomes co-
valently linked to one or two different polypeptides
w xof 80–90 kDa, named the heavy chains 2,27 . In rat
plasma, the major bikunin-containing protein is pre-
 .a-inhibitor unpublished observation , which consists
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w xof bikunin and one heavy chain 28 . Similarly, half
of the plasma a -microglobulin occurs in a complex1
w xwith fibronectin and a -inhibitor 3 10,11 . It is1
possible that part of the bikunin and a -microglobu-1
lin in the urine is formed by proteolytic degradation
w xof these complex molecules 29 . However, if this
process would be the major cause of the increased
urinary levels during pregnancy, the plasma concen-
trations of the two proteins in free form would in-
crease proportionally, which was not seen in this
study. However, for patients with inflammatory dis-
w xeases this appears to be the case 18 .
Based on the analysis of various proteins in human
w xurine, Bernard et al. 30 concluded that pregnancy
leads to an increase of the concentration of low
molecular weight proteins. Our results are consistent
with this finding; thus the levels of albumin and
orosomucoid were unchanged whereas those of
bikunin and a -microglobulin increased. It seems1
that this size specific effect is also evoked by other
situations of stress. Thus, the urinary secretion of
retinol binding protein, like that of bikunin, has been
shown to increase upon fever and inflammation
w x31,32 . The mechanism behind this change is un-
known but it seems to be mediated in part by the
w xcortisol production 33,34 .
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